Business Context and Reporting Period
Company: Nanophase Technologies Corporation (Note: Metadata listed "SOLESENCE, INC." but filing text confirms Nanophase Technologies Corporation).
Reporting Period: Quarterly period ended June 30, 2002 (Form 10-Q).
Business Overview: The Company develops and sells nanocrystalline materials for commercial production in healthcare, wear-resistant materials, Chemical Mechanical Planarization (CMP), and catalyst markets. The Company has incurred cumulative losses since inception and historically funds operations through equity issuances.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2002 | Six Months Ended June 30, 2001 |
|---|---|---|
| Total Revenue | $3,069,528 | $2,121,304 |
| Net Loss | $(2,747,392) | $(2,406,004) |
| Net Loss Per Share (Basic/Diluted) | $(0.20) | $(0.18) |
| Cash and Cash Equivalents (End of Period) | $530,965 | $995,065 |
| Total Investments | $10,175,857 | $6,842,956 |
| Total Current Assets | $12,896,221 | $9,943,900 |
| Total Current Liabilities | $2,497,721 | $2,728,380 |
| Long-Term Debt (Less Current) | $553,812 | $758,490 |
| Accumulated Deficit | $(37,501,580) | $(34,754,188) |
| Net Cash Used in Operating Activities | $(1,327,236) | $(1,618,502) |
| Net Cash Provided by Financing Activities | $5,182,487 | $914,444 |
Gross Margin: Cost of revenue was 84% of total revenue for the three months ended June 30, 2002 (down from 96% in the prior year quarter) and 88% for the six-month period (unchanged from prior year).
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 45% year-over-year for the six months ended June 30, 2002, driven by additional customers and growth with existing customers. Product revenue rose from $1.94 million to $2.83 million.
- Customer Concentration: Dependence on the largest customer increased significantly. This customer accounted for approximately 71% of total revenue for the three and six months ended June 30, 2002, compared to 46% and 60% respectively in the prior year.
- Operating Expenses: Selling, general, and administrative (SG&A) expenses decreased by approximately 6% for the six-month period, attributed to reduced bad debt, travel, and investor relations costs. Research and development (R&D) expenses increased by 25% due to increased depreciation on new assets and cessation of capitalizing salary expenses for construction projects.
- Liquidity Position: While cash and cash equivalents decreased slightly, total liquid assets (cash plus investments) increased from $7.43 million at year-end 2001 to $10.71 million at June 30, 2002, bolstered by a private placement.
Guidance, Outlook, Risks, and Unusual Items
- Capital Raise: On May 29, 2002, the Company completed a private placement of 1.37 million shares at $5.00 per share, receiving net proceeds of approximately $6.2 million. Management intends to use these funds for working capital and new market growth.
- Supply Agreement Contingency: A critical risk involves a supply agreement with the largest customer. The agreement contains "triggering events" (e.g., negative earnings combined with liquid assets under $4 million) that could force the Company to license technology or sell production equipment to the customer. Management believes the recent capital raise avoids this trigger for at least 12 months.
- Legal Proceedings:
- HarbourCourt LPI: A 1998 lawsuit regarding IPO disclosures was settled for $800,000 (funded by D&O insurance) in January 2002.
- George Tatz: A class action lawsuit filed in November 2001 alleges fraudulent misstatements regarding dealings with a British customer (Celox) and revenue booking. The Company filed a motion to dismiss in April 2002; the outcome is uncertain.
- Outlook: Management expects to remain operating at a positive annual gross profit margin. However, future capital requirements depend on customer acceptance, R&D progress, and potential unplanned growth. Additional financing may be required and could be dilutive.
Investor Verification Checklist
- Customer Concentration Risk: Verify the stability of the largest customer, which represents 71% of revenue, and the specific terms of the supply agreement regarding technology transfer triggers.
- Liquidity Sufficiency: Confirm that the $6.2 million in recent proceeds is sufficient to cover operating losses and capital expenditures for the next 12 months without triggering debt covenants.
- Legal Exposure: Monitor the status of the George Tatz class action lawsuit regarding revenue recognition practices.
- Capital Expenditures: Review the utilization of funds for the new pilot manufacturing and powder blending facilities to ensure they generate expected efficiencies.
- Inventory Valuation: Note the allowance for excess inventory quantities ($656,021) and assess the risk of further write-downs given the company's historical losses.